Clinical trial
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or…
NCT00433498 · University College, London, Other · Completed
Key facts
| NCT number | NCT00433498 |
|---|---|
| Title | Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer |
| Official title | A Multicentre Phase III Randomized Double Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients With Small Lung Cancer |
| Lead sponsor | University College, London, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, etoposide phosphate, pravastatin sodium |
| Enrollment | 846 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Nov 1, 2013 |
| First posted | Feb 12, 2007 |
| Last update posted | Dec 3, 2014 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: